Clinical Research Directory
Browse clinical research sites, groups, and studies.
Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease
Sponsor: Samsung Medical Center
Summary
Studies exploring the feasibility of drug-eluting balloon (DCB) in de-novo coronary lesions are limited. There are scarce data comparing DCB with drug-eluting stent (DES) in patients with high bleeding risk (HBR), a situation in which long-term maintenance of dual antiplatelet therapy (DAPT) is a clinical dilemma. This target trial emulation aims to compare clinical outcomes between DCB angioplasty and conventional DES implantation in de-novo coronary lesions in patients with coronary artery disease.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
470000
Start Date
2026-02-28
Completion Date
2026-12-31
Last Updated
2026-03-02
Healthy Volunteers
No
Interventions
Drug coated balloon
Patients receiving drug coated balloon angioplasty for de novo coronary artery disease
Drug-eluting stent
Patients receiving drug-eluting stent implantationfor de novo coronary artery disease
Locations (1)
Samsung Medical Center
Seoul, South Korea